IOVANCE BIOTHERAPEUTICS FACILITY GROUNDBREAKING AT THE NAVY YARD

by PIDCphila
July 29, 2019

Explore Categories

[av_one_full first min_height=” vertical_alignment=” space=” custom_margin=” margin=’0px’ padding=’0px’ border=” border_color=” radius=’0px’ background_color=” src=” background_position=’top left’ background_repeat=’no-repeat’ animation=” mobile_breaking=” mobile_display=”]
[av_textblock size=” font_color=” color=” av-medium-font-size=” av-small-font-size=” av-mini-font-size=” custom_class=” admin_preview_bg=”]
Iovance Biotherapeutics, Inc., a late-stage biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) technology, hosted a groundbreaking ceremony to build an approximately 136,000 square foot commercial-scale production facility at the Navy Yard. Check out our photo gallery covering the June event. Read more about the facility and the amazing work of Iovance Biotherapeutics, Inc. here on the Navy Yard Blog.
[/av_textblock]
[/av_one_full]

[av_gallery ids=’7379,7383,7381,7382,7380′ style=’big_thumb’ preview_size=’portfolio_small’ crop_big_preview_thumbnail=’avia-gallery-big-crop-thumb’ thumb_size=’portfolio_small’ columns=’5′ imagelink=’lightbox’ lazyload=’avia_lazyload’ custom_class=” admin_preview_bg=”]

Explore Categories